首页> 美国卫生研究院文献>Thorax >Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler.
【2h】

Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler.

机译:微处理器控制的加压定量吸入器给药后人肺中的气溶胶沉积。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND--Gamma scintigraphy was employed to assess the deposition of aerosols emitted from a pressurised metered dose inhaler (MDI) contained in a microprocessor controlled device (SmartMist), a system which analyses an inspiratory flow profile and automatically actuates the MDI when predefined conditions of flow rate and cumulative inspired volume coincide. METHODS--Micronised salbutamol particles contained in a commercial MDI (Ventolin) were labelled with 99m-technetium using a method validated by the determination of (1) aerosol size characteristics of the drug and radiotracer following actuation into an eight stage cascade impactor and (2) shot potencies of these non-volatile components as a function of actuation number. Using nine healthy volunteers in a randomised factorial interaction design the effect of inspiratory flow rate (slow, 30 l/min; medium, 90 l/min; fast, 270 l/min) combined with cumulative inspired volume (early, 300 ml; late, 3000 ml) was determined on total and regional aerosol lung deposition using the technique of gamma scintigraphy. RESULTS--The SmartMist firing at the medium/early setting (medium flow and early in the cumulative inspired volume) resulted in the highest lung deposition at 18.6 (1.42)%. The slow/early setting gave the second highest deposition at 14.1 (2.06)% with the fast/late setting resulting in the lowest (7.6 (1.15)%). Peripheral lung deposition obtained for the medium/early (9.1 (0.9)%) and slow/early (7.5 (1.06)%) settings were equivalent but higher than those obtained with the other treatments. This reflected the lower total lung deposition at these other settings as no difference in regional deposition, expressed as a volume corrected central zone:peripheral zone ratio, was apparent for all modes of inhalation studied. CONCLUSIONS--The SmartMist device allowed reproducible actuation of an MDI at a preprogrammed point during inspiration. The extent of aerosol deposition in the lung is affected by a change in firing point and is promoted by an inhaled flow rate of up to 90 l/min-that is, the slow and medium setting used in these studies.
机译:背景技术-伽玛闪烁显像术用于评估微处理器控制的设备(SmartMist)中包含的加压计量吸入器(MDI)排放的气溶胶的沉积情况,该系统可分析吸气流量分布并在预定义条件下自动启动MDI。流速和累积吸气量一致。方法-使用一种经以下方法验证的方法,用99m labeled标记商品MDI(Ventolin)中包含的微粉沙丁胺醇颗粒:(1)驱动八级级联撞击器后,确定(1)药物和放射性示踪剂的气溶胶尺寸特征,并且(2 )这些非挥发性成分的激发力与驱动次数的关系。使用9名健康志愿者进行随机因子交互设计,得出吸气流速(缓慢的30 l / min;中等的90 l / min;快速的270 l / min)与累积的吸气量(早期300 ml;晚期)的关系,3000毫升)使用γ闪烁显像技术确定了全部和局部气溶胶肺沉积。结果-在中/早期设置(中等流量和累积吸气量的早期)进行SmartMist射击导致最高的肺部沉积,为18.6(1.42)%。缓慢/较早的设置产生了第二高的沉积,为14.1(2.06)%,而快速/较晚的设置产生了最低的(7.6(1.15)%)。中/早(9.1(0.9)%)和慢/早(7.5(1.06)%)设置获得的周围肺沉积是等效的,但高于其他治疗方法。这反映了在这些其他设置下较低的总肺部沉积,因为在研究的所有吸入模式下,区域沉积均无明显差异(以体积校正的中央区与周围区之比表示)。结论-SmartMist设备允许在吸气过程中在预编程的点上对MDI进行可重现的驱动。肺中气溶胶的沉积程度受着火点的变化影响,吸入流速高达90 l / min(即这些研究中使用的慢速和中等速度)会促进这种变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号